First Fiduciary Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$522K Sell
435
-40
-8% -$40.9K 0.1% 56
2026
Q1
$437K Sell
475
-25
-5% -$25.3K 0.09% 51
2025
Q4
$537K Hold
500
0.1% 54
2025
Q3
$381K Hold
500
0.07% 60
2025
Q2
$390K Buy
+500
New +$389K 0.08% 58
2014
Q4
Sell
-165,285
Closed -$10.7M 43
2014
Q3
$10.7M Sell
165,285
-5,715
-3% -$362K 2.43% 27
2014
Q2
$10.6M Buy
171,000
+1,585
+0.9% +$94.6K 2.34% 25
2014
Q1
$9.97M Sell
169,415
-2,475
-1% -$138K 2.28% 25
2013
Q4
$8.77M Buy
+171,890
New +$8.61M 2.04% 32

Other funds holding LLY

First Fiduciary Investment Counsel's LLY Position: Q2 2026 in Review

First Fiduciary Investment Counsel reduced its Eli Lilly (LLY) stake by 8.4% in Q2 2026, selling an estimated $40.9K and leaving 435 shares worth $522K. The position accounts for 0.1% of the portfolio, ranked #56.

First Fiduciary Investment Counsel first reported a position in LLY in Q4 2013 and has held it in 9 quarters since. The position peaked at $10.7M in Q3 2014. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • First Fiduciary Investment Counsel held 435 shares of Eli Lilly worth $522K as of Q2 2026.
  • First Fiduciary Investment Counsel sold 40 Eli Lilly shares in Q2 2026, an estimated $40.9K.
  • Eli Lilly made up 0.1% of First Fiduciary Investment Counsel's portfolio in Q2 2026, its #56 holding.
  • First Fiduciary Investment Counsel first reported a position in Eli Lilly in Q4 2013 and has held it in 9 quarters since.
  • First Fiduciary Investment Counsel's Eli Lilly position peaked at $10.7M in Q3 2014.
  • 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on First Fiduciary Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.